α‐Synuclein strain homogeneity in multiple system atrophy subtypes
Brain Pathology · 14.08.2026
DOI: 10.1111/bpa.70134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 14.08.2026. Verfasst von Heather H C Lau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Conformationally distinct “strains” of α‐synuclein aggregates are believed to contribute to the clinical and pathological diversity observed among synucleinopathies such as multiple system atrophy (MSA) and Parkinson's disease. Cases of MSA can be classified into two distinct subtypes: the cerebellar variant, MSA‐C, and the parkinsonian variant, MSA‐P, as determined by differences in their clinical and/or neuropathological presentations. To assess whether distinct α‐synuclein strains may be present in individuals with MSA‐C versus MSA‐P, we characterized the conformational and seeding properties of α‐synuclein aggregates in various brain regions from MSA‐C and MSA‐P patients and performed propagation studies in M83 transgenic mice. Biochemical fingerprinting of α‐synuclein aggregates using limited proteolysis and a conformational stability assay failed to reveal differences between MSA‐C and MSA‐P either before or after propagation in mice. Similarly, using brain extracts from either MSA patients or MSA‐inoculated mice, MSA‐C and MSA‐P α‐synuclein aggregates exhibited indistinguishable seeding attributes in a seed amplification assay. Finally, no differences were observed in either the kinetics of disease progression or the extent of cerebral α‐synuclein deposition in M83 mice inoculated with either MSA‐C or MSA‐P, regardless of the brain region from which the injected α‐synuclein aggregates were derived. These results suggest that MSA subtypes are unlikely to arise because of distinct α‐synuclein strains. Instead, our findings support a model in which the same α‐synuclein strain initially forms in different brain regions, leading to differences in disease manifestation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
- Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
- Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
- Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
- Neuroscience Program, Harvard Medical School, Boston, Massachusetts, USA.
- Krembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Heather H C Lau, Nicholas R G Silver, Raphaella W L So, Le Yao Li, Erica Stuart, Bradley T Hyman, Martin Ingelsson, Joel C Watts
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Lau, H. H. C., Silver, N. R. G., Mehra, S., So, R. W. L., Li, L. Y., Mao, A., Stuart, E., Schmitt-Ulms, C., Hyman, B. T., Ingelsson, M., & Watts, J. C. (2026). α‐Synuclein strain homogeneity in multiple system atrophy subtypes. Brain Pathology. https://doi.org/10.1111/bpa.70134
Vancouver
Lau HHC, Silver NRG, Mehra S, So RWL, Li LY, Mao A, et al. α‐Synuclein strain homogeneity in multiple system atrophy subtypes. Brain Pathology. 2026. doi:10.1111/bpa.70134
BibTeX
@article{Lau2026,
author = {Lau, Heather H C and Silver, Nicholas R G and Mehra, Surabhi and So, Raphaella W L and Li, Le Yao and Mao, Alison and Stuart, Erica and Schmitt-Ulms, Cian and Hyman, Bradley T and Ingelsson, Martin and Watts, Joel C},
title = {α‐Synuclein strain homogeneity in multiple system atrophy subtypes},
journal = {Brain Pathology},
year = {2026},
doi = {10.1111/bpa.70134}
}
EUVIMED